Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.
about
Epicardial Fat: Physiological, Pathological, and Therapeutic ImplicationsAdiponectin signaling and function in insulin target tissuesFibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan CrosstalkMolecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 DiabetesAdiponectin as a potential biomarker of vascular diseaseAMPK: a cellular metabolic and redox sensor. A minireviewEndogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart diseaseCardiometabolic effects of adiponectinTranslating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitineAPPL proteins FRET at the BAR: direct observation of APPL1 and APPL2 BAR domain-mediated interactions on cell membranes using FRET microscopyN-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic ratsA highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectinDivergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.Adiponectin and insulin cross talk: the microvascular connection.Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin deliveryOverexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivityAdiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes.Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides.Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthaseYin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cellsRegulation of Microvascular Function by Adipose Tissue in Obesity and Type 2 Diabetes: Evidence of an Adipose-Vascular Loop.Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway.Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblastsAdiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial DysfunctionGlobular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosisAdipokines and vascular health in treated HIV infection: an obesity paradox?The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout miceAdiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway.An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.Absence of Appl2 sensitizes endotoxin shock through activation of PI3K/Akt pathway.Emerging role of adipokines as mediators in atherosclerosis.Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicityAdiponectin provides cardiovascular protection in metabolic syndrome.Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.Gender differences in adiponectin modulation of cardiac remodeling in mice deficient in endothelial nitric oxide synthase.Expression of brain adiponectin in a murine model of transient cerebral ischemia.Adiponectin receptor 1 C-terminus interacts with PDZ-domain proteins such as syntrophins.Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver diseaseThe adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway
P2860
Q26746996-786E930E-69FB-4B51-8E84-381959B364F1Q26753354-0F62AE08-2EF1-48CA-A66F-1570A9501FF1Q26766528-90C08BCF-B77C-4CAB-A9AC-74F34F9CB64DQ26782445-FA96BEFF-C6A7-407D-9A69-72F6BE4E9D77Q26821925-813C9CEF-E09B-4F76-B087-64333911ADF0Q26995682-3A0B7194-DA9D-4382-AB50-2832F9231674Q27010136-CE94AAF2-9CDE-4574-8D54-3284EC614434Q27027840-A69E4835-A467-49FB-B501-25E80F3CCCBDQ28395286-EC659A46-88BD-422F-A200-DACE72354547Q28475350-229440B1-E0E9-478A-A5CB-0CEF6A3397D6Q28476775-215C4418-C7CD-489C-9C3B-C11030EBFA24Q28508158-3A458556-1DCC-4421-86EC-4CA34543638AQ28591569-DEBBFCB3-ACE3-4D0A-AEBA-3DEF3CF8C5ECQ30370241-23A01BD3-23A6-4FAA-BA93-5E60F5660925Q30413976-B7610D36-1DE6-4822-871D-73D9AD77BCC2Q30423827-CAA9582F-07D1-4436-A3E5-7FF1306266CCQ30440168-E80FA8E0-ADA7-4D78-8201-1E0516328C80Q30555227-25268D57-3447-4D47-8633-4CB6B2F1FE0CQ30829817-265B33E6-5B8E-46AD-AF7D-A7559683C590Q30850845-741BB1C9-B47D-425F-8C82-08F6D9625B4FQ33553662-1C06C90A-3294-416B-A74E-4787DC2136CCQ33602767-663D9194-80EB-481F-8057-142EAA15CFA3Q33642616-5407085A-7FED-42E9-AEB6-5239D99916D2Q33673656-CC8568BB-0E46-4E03-B37C-778D009ACB80Q33839167-231AA11D-47BB-4F7F-82D2-5ABE9C977A73Q33892702-7DEFBF26-4532-416D-8E7B-941CEE720777Q34075808-80FE16FF-7E86-474E-9123-AC33B8F112BDQ34150518-B2E50FB3-28E2-4F0E-98A5-E6B27D71A85DQ34237779-618AAE38-7605-4AC7-AC2F-9457D62E26D1Q34305220-CB94D4FC-3222-41FF-8906-9653316A1CDBQ34363156-A9F862DF-FDCF-4C9D-967F-D16470035FDAQ34427067-3365B6B7-C225-4B48-ABAC-1B5CEAF24ABCQ34540588-2C9F3466-4C8F-41D1-B6A4-31FDE930F649Q34557564-9F1FB3F4-AFEE-4396-B306-293E8533B861Q34635250-11B64510-7D59-439F-BD05-9BFB8158CF46Q34721083-B2AC786C-5EC1-42BF-8EC0-41D8381EF8FCQ34770224-FDD50CAA-B615-439E-BECA-08D783199088Q34824199-D18F2FF7-BA7F-49EF-88C4-1C2E1CA1EE8EQ34971028-C8146E05-8399-4FC3-A92D-5192F1FF1C55Q35043710-F16958B8-FCCA-4D45-9AEF-66ADA22F9581
P2860
Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells.
@en
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells.
@nl
type
label
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells.
@en
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells.
@nl
prefLabel
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells.
@en
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells.
@nl
P2093
P50
P356
P1433
P1476
Adiponectin-induced endothelia ...... by APPL1 in endothelial cells
@en
P2093
Chiwai Wong
Donghai Wu
Karen S L Lam
P304
P356
10.2337/DB06-1580
P407
P577
2007-02-07T00:00:00Z